The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This stock page is the Follow view. The Build view lets your agent query UNCY owners, fund changes, insider filings, and source links through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/UNCY"
Use Arkolith to show who owns UNCY, which funds added or reduced it, and which SEC filings prove each claim.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | $6.2M | 939K | —Held | Q1 2026 | |
| 2 | Logos Global Management LP | $3.1M | 474K | —Held | Q1 2026 | |
| 3 | CITADEL ADVISORS LLC | $1.6M | 237K | ▼−8.3% Reduced · −21K sh | Q1 2026 | |
| 4 | Integral Health Asset Management, LLC | $1.5M | 225K | ▲New +225K sh | Q1 2026 | |
| 5 | VANGUARD FIDUCIARY TRUST CO | $665K | 101K | ▲New +101K sh | Q1 2026 | |
| 6 | STATE STREET CORP | $527K | 80K | ▲+23% Added · +15K sh | Q1 2026 | |
| 7 | Quadrature Capital Ltd | $184K | 28K | ▼−29% Reduced · −11K sh | Q1 2026 | |
| 8 | Chicago Partners Investment Group LLC | $168K | 22K | ▼−2.8% Reduced · −635 sh | Q1 2026 | |
| 9 | SBI Securities Co., Ltd. | $4K | 557 | ▼−0.2% Reduced · −1 sh | Q1 2026 | |
| 10 | DANSKE BANK A/S | $7 | 1 | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| May 14, 2026 | Jermasek Douglas | EVP, Corporate Strategy | Grant (A) | 170K | $0 |
| May 14, 2026 | Laumas Sandeep | Director | Grant (A) | 42K | $0 |
| May 14, 2026 | Laumas Sandeep | Director | Grant (A) | 84K | $0 |
| May 14, 2026 | Kenkare-Mitra Sara | Director | Grant (A) | 84K | $0 |
| May 14, 2026 | Kenkare-Mitra Sara | Director | Grant (A) | 42K | $0 |
| May 14, 2026 | Gupta Pramod | EVP, Pharmaceuticals and BD | Grant (A) | 170K | $0 |
| May 14, 2026 | Gupta Shalabh K. | CEO, Director | Grant (A) | 762K | $0 |
| May 14, 2026 | Townsend John | CFO | Grant (A) | 170K | $0 |
| Aug 25, 2025 | Aggarwal Gaurav | Director | Disposed to issuer (D) | 3K | $3.2M |
| Aug 25, 2025 | Aggarwal Gaurav | Director | Conversion (C) | 653K | — |
| Jul 28, 2025 | Jermasek Douglas | EVP of Corporate Strategy | Grant (A) | 10K | $0 |
| Jul 28, 2025 | Gupta Pramod | EVP, Pharmaceuticals and BD | Grant (A) | 90K | $0 |
| Company | Co-held by | Combined value |
|---|---|---|
| REVOLUTION MEDICINES INCRVMD | 8 funds | $390.2M |
| BIOGEN INCBIIB | 8 funds | $83.7M |
| ELI LILLY & COLLY | 7 funds | $1.5B |
| UNITEDHEALTH GROUP INCUNH | 7 funds | $935.4M |
| INTUITIVE SURGICAL INCISRG | 7 funds | $900.2M |
| GILEAD SCIENCES INCGILD | 7 funds | $710.9M |
| CARDINAL HEALTH INCCAH | 7 funds | $584.7M |
| ELEVANCE HEALTH INCELV | 7 funds | $543.7M |
| CVS HEALTH CORPCVS | 7 funds | $481.6M |
| BOSTON SCIENTIFIC CORPBSX | 7 funds | $451.4M |
| MADRIGAL PHARMACEUTICALS INCMDGL | 7 funds | $307.1M |
| VERTEX PHARMACEUTICALS INCVRTX | 7 funds | $300.1M |
Ranked by how many of UNCY's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for UNCY. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.